Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riva Brik

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Arthritis Care & Research|December 17, 2013
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritisFriederike Rothmund, Joachim Gerss, Nicolino Ruperto, et al.
Arthritis Research & Therapy|January 25, 2017
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapyArndt H Brachat, Alexei A Grom, Nico Wulffraat, et al.
Arthritis and Rheumatism|January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation studyNicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
The New England Journal of Medicine|December 21, 2012
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Annals of the Rheumatic Diseases|April 24, 2010
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaSeza Ozen, Angela Pistorio, Silvia M Iusan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Arthritis Care & Research|December 17, 2013
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritisFriederike Rothmund, Joachim Gerss, Nicolino Ruperto, et al.
Arthritis Research & Therapy|January 25, 2017
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapyArndt H Brachat, Alexei A Grom, Nico Wulffraat, et al.
Arthritis and Rheumatism|January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation studyNicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
The New England Journal of Medicine|December 21, 2012
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Annals of the Rheumatic Diseases|April 24, 2010
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaSeza Ozen, Angela Pistorio, Silvia M Iusan, et al.
Pageof 5